Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction.
Schmeißer A, Rauwolf T, Groscheck T, Fischbach K, Kropf S, Luani B, Tanev I, Hansen M, Meißler S, Schäfer K, Steendijk P, Braun-Dullaeus RC. Schmeißer A, et al. Among authors: rauwolf t. ESC Heart Fail. 2021 Aug;8(4):2968-2981. doi: 10.1002/ehf2.13386. Epub 2021 May 2. ESC Heart Fail. 2021. PMID: 33934536 Free PMC article. Clinical Trial.
Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trial.
Christoph M, Herold J, Berg-Holldack A, Rauwolf T, Ziemssen T, Schmeisser A, Weinert S, Ebner B, Said S, Strasser RH, Braun-Dullaeus RC. Christoph M, et al. Among authors: rauwolf t. Heart Vessels. 2015 May;30(3):286-95. doi: 10.1007/s00380-014-0480-0. Epub 2014 Feb 12. Heart Vessels. 2015. PMID: 24519403 Clinical Trial.
Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone on Peripheral Vessel Function and Clinical Parameters in Nondiabetic Patients: A Double-Center, Randomized Controlled Pilot Trial.
Christoph M, Herold J, Berg-Holldack A, Rauwolf T, Ziemssen T, Schmeisser A, Weinert S, Ebner B, Ibrahim K, Strasser RH, Braun-Dullaeus RC. Christoph M, et al. Among authors: rauwolf t. Cardiology. 2015;131(3):165-71. doi: 10.1159/000376570. Epub 2015 May 6. Cardiology. 2015. PMID: 25967848 Clinical Trial.
Zero-fluoroscopy cryothermal ablation of atrioventricular nodal re-entry tachycardia guided by endovascular and endocardial catheter visualization using intracardiac echocardiography (Ice&ICE Trial).
Luani B, Zrenner B, Basho M, Genz C, Rauwolf T, Tanev I, Schmeisser A, Braun-Dullaeus RC. Luani B, et al. Among authors: rauwolf t. J Cardiovasc Electrophysiol. 2018 Jan;29(1):160-166. doi: 10.1111/jce.13354. Epub 2017 Oct 26. J Cardiovasc Electrophysiol. 2018. PMID: 28960632
Left atrial enlargement and clinical considerations in patients with or without a residual interatrial shunt after closure of the left atrial appendage with the WATCHMAN™-device.
Luani B, Groscheck T, Genz C, Tanev I, Rauwolf T, Herold J, Medunjanin S, Schmeisser A, Braun-Dullaeus RC. Luani B, et al. Among authors: rauwolf t. BMC Cardiovasc Disord. 2017 Dec 12;17(1):294. doi: 10.1186/s12872-017-0728-6. BMC Cardiovasc Disord. 2017. PMID: 29233088 Free PMC article.
41 results